AEON is the former parent company of EOLS, which sells Jeuveau botulinum toxin for aesthetic indications. AEON’s ABP-450 is the exact same product as EOLS’ Jeuveau (sourced from Korea’s Daewoong), but AEON intends to seek FDA approval in therapeutic indications only.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.